Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. | 207,154 | reported | 17 Jun 2025 | tx 6+212,154−5,000 |
| Monte Rosa Therapeutics, Inc. | 30,700 | reported | 13 Jun 2025 | tx 4+114,300 |
| Trillium Therapeutics Inc. | 0 | reported | 17 Nov 2021 | tx 17+155,500−2,270,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 17 Jun 2025 | GRANT_AWARD | Zentalis Pharmaceuticals, Inc. | 57,603 | 0.00 USD | |
| 13 Jun 2025 | GRANT_AWARD | Monte Rosa Therapeutics, Inc. | 30,700 | 0.00 USD | deriv |
| 31 Jan 2025 | PURCHASE | Zentalis Pharmaceuticals, Inc. | 60,000 | 1.72 USD | |
| 21 Jun 2024 | GRANT_AWARD | Zentalis Pharmaceuticals, Inc. | 41,581 | 0.00 USD | |
| 12 Jun 2024 | GRANT_AWARD | Monte Rosa Therapeutics, Inc. | 22,100 | 0.00 USD | deriv |
| 11 Sept 2023 | SALE | Zentalis Pharmaceuticals, Inc. | 5,000 | 25.05 USD | |
| 16 Jun 2023 | GRANT_AWARD | Zentalis Pharmaceuticals, Inc. | 16,364 | 0.00 USD | |
| 14 Jun 2023 | GRANT_AWARD | Monte Rosa Therapeutics, Inc. | 20,500 | 0.00 USD | deriv |
| 30 Mar 2023 | GRANT_AWARD | Monte Rosa Therapeutics, Inc. | 41,000 | 0.00 USD | deriv |
| 09 Sept 2022 | GRANT_AWARD | Zentalis Pharmaceuticals, Inc. | 36,606 | 0.00 USD | |
| 17 Nov 2021 | OTHER | Trillium Therapeutics Inc. | 197,000 | 0.00 USD | deriv |
| 17 Nov 2021 | OTHER | Trillium Therapeutics Inc. | 1,162,500 | 0.00 USD | deriv |
| 17 Nov 2021 | OTHER | Trillium Therapeutics Inc. | 600,000 | 0.00 USD | deriv |
| 11 May 2021 | SALE | Trillium Therapeutics Inc. | 106,698 | 9.20 USD | |
| 11 May 2021 | EXERCISE | Trillium Therapeutics Inc. | 19,198 | 0.31 USD | |
| 11 May 2021 | EXERCISE | Trillium Therapeutics Inc. | 87,500 | 0.45 USD | |
| 12 May 2021 | SALE | Trillium Therapeutics Inc. | 23,802 | 9.24 USD | |
| 12 May 2021 | EXERCISE | Trillium Therapeutics Inc. | 23,802 | 0.31 USD | |
| 12 May 2021 | EXERCISE | Trillium Therapeutics Inc. | 23,802 | 0.00 USD | deriv |
| 11 May 2021 | EXERCISE | Trillium Therapeutics Inc. | 87,500 | 0.00 USD | deriv |
| 11 May 2021 | EXERCISE | Trillium Therapeutics Inc. | 19,198 | 0.00 USD | deriv |
| 14 Jan 2021 | EXERCISE | Trillium Therapeutics Inc. | 19,581 | 0.43 USD | |
| 13 Jan 2021 | SALE | Trillium Therapeutics Inc. | 5,419 | 15.04 USD | |
| 13 Jan 2021 | EXERCISE | Trillium Therapeutics Inc. | 5,419 | 0.42 USD | |
| 14 Jan 2021 | SALE | Trillium Therapeutics Inc. | 19,581 | 15.03 USD |